Kumbhojkar, Ninad http://orcid.org/0000-0002-0097-2593
Prakash, Supriya
Fukuta, Tatsuya
Adu-Berchie, Kwasi
Kapate, Neha http://orcid.org/0000-0003-4576-0014
An, Rocky http://orcid.org/0000-0003-0944-1358
Darko, Solomina
Chandran Suja, Vineeth http://orcid.org/0000-0002-3406-7655
Park, Kyung Soo
Gottlieb, Alexander P.
Bibbey, Michael Griffith http://orcid.org/0009-0002-9449-5384
Mukherji, Malini
Wang, Lily Li-Wen
Mooney, David J. http://orcid.org/0000-0001-6299-1194
Mitragotri, Samir http://orcid.org/0000-0002-2459-8305
Funding for this research was provided by:
Harvard University | Faculty of Arts and Sciences (School of Engineering)
National Science Foundation (ECCS-2025158, 1122374, 2140743, 2140743)
Uehara Memorial Foundation, New Pharmaceutical Technology and Engineering Foundation
Article History
Received: 8 April 2023
Accepted: 2 February 2024
First Online: 29 February 2024
Competing interests
: N. Kumbhojkar, S.P., N. Kapate, L.L.-W.W. and S.M. are inventors of patent applications related to the technologies discussed in this work. These patents are owned and managed by Harvard University. S.M. declares the following interests: Hitch Bio, board member, equity; and Asalyxa, scientific advisory board (SAB), equity. D.J.M. declares the following competing interests: Novartis, sponsored research, licensed intellectual property; Immulus, equity; IVIVA, SAB; Attivare, SAB, equity; and Lyell, licensed intellectual property, equity. The other authors declare no competing interests.